Press Releases

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, have announced a partnership that uses synthetic data to help researchers more easily develop drugs to treat rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together with real data, these synthetic data will help maximize the utility of C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), which provides a standardized and centralized infrastructure to...

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct investment, access to Azure Cloud computing, and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck. The MDSS is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation. McKesson Ventures is one...

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and above, including the C-suite and the board of directors. Parity.org is a 501(c)(3) not-for-profit organization focused on bringing gender and racial equality to the highest levels of business, calling for “Equal Representation. Now.” “We are proud to be involved in the ParityPledge,”...

OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation

OncoHealth announced today that Arsenal Capital Partners and McKesson Corporation have strategically invested in the company. The funding, which gives Arsenal a majority ownership stake in OncoHealth, will help the company continue developing its oncology-focused digital health platform. John DiGiovanni, an Investment Partner at Arsenal said of the investment, “Arsenal is focused on helping to build businesses that are tackling healthcare’s most pressing challenges.” He continued, “…OncoHealth is removing administrative burdens for health plans and providers, facilitating stakeholder alignment, and improving the patient experience.” Brian Tyler, CEO...

Reimagine Care and University of Colorado Anschutz Medical Campus Collaborate to Provide Home-Centered Care to Bone Marrow Transplant Patients

Reimagine Care, a provider of technology-enabled services that support oncologists in delivering high-quality, home-centered, value-based cancer care, has collaborated with the University of Colorado Anschutz Medical Campus (CU Anschutz) to deliver care to bone marrow transplant patients. The collaboration will leverage specialized clinical technology, advanced remote patient monitoring (RPM), and Reimagine Care’s Virtual Care Center to detect infections earlier and begin life-saving treatments faster to improve outcomes and enhance patient and caregiver experience. Bone marrow transplant patients are especially vulnerable post-transplant because their immune systems are...

OncoHealth Launches New Consumer Platform Bringing Digital Telehealth Services to People with Cancer

OncoHealth, a leading digital health company dedicated to oncology, today unveiled a new digital telehealth service for people with cancer. Iris™ by OncoHealth combines human-centered design, mobile technology, data, empathy, and specially trained oncology experts to deliver personalized, oncology-specific, 24x7 telehealth support to patients and their families facing cancer. OncoHealth will launch Iris in collaboration with three of the nation’s leading health plans—Point32Health, HealthPartners, and a large regional plan in the Midwest. Beginning this spring, all three plans will begin a defined roll-out to a subset...

Augmedix to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022

Medical data service and documentation provider Augmedix recently announced that its fourth quarter and 2021 financial results will be reported on Monday, March 21, 2022, after market close. A conference call discussing these numbers will be held by company management at 1:30 p.m. Pacific Time. There are several ways to hear the conference call: Those who are interested can find a webcast of the event on the company’s website, https://ir.augmedix.com/news-events/ir-calendar. U.S. callers can dial 877-407-3982 and international callers can dial +1 (201) 493-6780 to access the...

CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention

CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, has closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. Other investors participating in the round were McKesson Ventures; OSF HealthCare; a current health system customer; and CancerIQ’s Series A lead investor, HealthX Ventures. This funding round comes one month after a report from the President’s Cancer Panel calling for “urgent and immediate action” to close gaps in cancer screening, risk assessment,...

IVX Health to Open Three New Infusion Centers in Southwest Florida to Care for Patients Living with Complex Chronic Conditions

IVX Health recently announced the opening of three new centers in Florida’s Southwest in the spring. The centers will be located in the communities of Fort Myers, Naples, and Estero. The company is known as a nationwide provider of injection and infusion therapy focused on treating patients with complex chronic diseases like rheumatoid arthritis, multiple sclerosis, and Crohn’s disease. The new centers will emphasize a focus on patients, including access to high-speed Wi-Fi, complimentary snacks, and flat screen TVs in the guaranteed private suites. IVX Health centers differ from...

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing investors McKesson Ventures, Waterline Ventures, Mountain Capital, Merck Global Health Innovation Fund, and Novartis were also part of the funding round. This announcement put Koneksa’s gross proceeds raised at a total of $65 million. Matrix Senior Managing Director Karan Takhar will be joining Koneksa’s...